Cargando…
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ferrata Storti Foundation
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049363/ https://www.ncbi.nlm.nih.gov/pubmed/31296572 http://dx.doi.org/10.3324/haematol.2018.214882 |
| _version_ | 1783502424307138560 |
|---|---|
| author | Kuusanmäki, Heikki Leppä, Aino-Maija Pölönen, Petri Kontro, Mika Dufva, Olli Deb, Debashish Yadav, Bhagwan Brück, Oscar Kumar, Ashwini Everaus, Hele Gjertsen, Bjørn T. Heinäniemi, Merja Porkka, Kimmo Mustjoki, Satu Heckman, Caroline A. |
| author_facet | Kuusanmäki, Heikki Leppä, Aino-Maija Pölönen, Petri Kontro, Mika Dufva, Olli Deb, Debashish Yadav, Bhagwan Brück, Oscar Kumar, Ashwini Everaus, Hele Gjertsen, Bjørn T. Heinäniemi, Merja Porkka, Kimmo Mustjoki, Satu Heckman, Caroline A. |
| author_sort | Kuusanmäki, Heikki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7049363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Ferrata Storti Foundation |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70493632020-04-07 Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia Kuusanmäki, Heikki Leppä, Aino-Maija Pölönen, Petri Kontro, Mika Dufva, Olli Deb, Debashish Yadav, Bhagwan Brück, Oscar Kumar, Ashwini Everaus, Hele Gjertsen, Bjørn T. Heinäniemi, Merja Porkka, Kimmo Mustjoki, Satu Heckman, Caroline A. Haematologica Aticle Ferrata Storti Foundation 2020-03 /pmc/articles/PMC7049363/ /pubmed/31296572 http://dx.doi.org/10.3324/haematol.2018.214882 Text en Copyright© 2020 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. |
| spellingShingle | Aticle Kuusanmäki, Heikki Leppä, Aino-Maija Pölönen, Petri Kontro, Mika Dufva, Olli Deb, Debashish Yadav, Bhagwan Brück, Oscar Kumar, Ashwini Everaus, Hele Gjertsen, Bjørn T. Heinäniemi, Merja Porkka, Kimmo Mustjoki, Satu Heckman, Caroline A. Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title | Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title_full | Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title_fullStr | Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title_full_unstemmed | Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title_short | Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| title_sort | phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia |
| topic | Aticle |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049363/ https://www.ncbi.nlm.nih.gov/pubmed/31296572 http://dx.doi.org/10.3324/haematol.2018.214882 |
| work_keys_str_mv | AT kuusanmakiheikki phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT leppaainomaija phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT polonenpetri phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT kontromika phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT dufvaolli phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT debdebashish phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT yadavbhagwan phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT bruckoscar phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT kumarashwini phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT everaushele phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT gjertsenbjørnt phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT heinaniemimerja phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT porkkakimmo phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT mustjokisatu phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia AT heckmancarolinea phenotypebaseddrugscreeningrevealsassociationbetweenvenetoclaxresponseanddifferentiationstageinacutemyeloidleukemia |